Table 1.
CTC Isolation Technique |
Method | Tumor Type | Clinical Objective | Major Advantages |
Major Disadvantages |
Ref. | |
---|---|---|---|---|---|---|---|
Label-Dependent Isolation |
Magnetic nanoparticles |
Antibody conjugation to magnetic nanoparticles selectively linked to specific markers expressed by CTCs | Breast Colorectal Prostate Ovarian |
Prognosis Treatment |
High capture Very Fast |
Expensive Low cell viability Low sensitivity |
[27] |
Microfluidic chip | Microfluidic chip with functionalized Surfaces in controlled flow to enhance CTC binding to antibody |
Breast Prostate Pancreatic Lung |
Diagnosis Prognosis Treatment |
Cheap High sensitivity High efficiency High cell variability |
Small sample vol. Slow flow rate |
[28,29] | |
Dual modality | Microfluidic platform (columns) with micromagnetic particles functionalized (EpCAM) | Breast Prostate NSCLC Colorectal |
Prognosis Diagnosis |
Very high efficiency Very high purity |
Expensive Medium sensitivity |
[30] |
Abbreviations: NSCLC: non-small-cell lung cancer; EpCAM: epithelial cell adhesion molecule.